Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States-Reference-Cited by-同舟云学术

Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States

Published:2021-07-05 Issue:4 Volume:54 Page:481-492
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Wijarnpreecha Karn¹^ORCID,Li Fang²^ORCID,Xiang Yang³^ORCID,Xu Xun⁴,Zhu Cong⁴,Maroufy Vahed⁵,Wang Qing²,Tao Wei⁵,Dang Yifang²,Pham Huy Anh²,Zhou Yujia²,Li Jianfu²,Zhang Xinyuan²,Xu Hua²^ORCID,Taner C. Burcin¹,Yang Liu¹,Tao Cui²^ORCID

Affiliation:

1. Department of Transplantation Mayo Clinic Jacksonville FL USA

2. School of Biomedical Informatics The University of Texas Health Science Center at Houston Houston TX USA

3. Peng Cheng Laboratory Shenzhen China

4. Department of Epidemiology, Human Genetics and Environmental Sciences School of Public Health The University of Texas Health Science Center at Houston Houston TX USA

5. Department of Biostatistics and Data Science School of Public Health The University of Texas Health Science Center at Houston Houston TX USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16490

Reference45 articles.

1. The Epidemiology of Cirrhosis in the United States

2. Liver cirrhosis

3. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites

4. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

5. Is it time to replace propranolol with carvedilol for portal hypertension?

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation;Clinical & Experimental Metastasis;2024-01-05

2. WGCNA combined with machine learning to find potential biomarkers of liver cancer;Medicine;2023-12-15

3. A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma;Digestive and Liver Disease;2023-08

4. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis;Frontiers in Pharmacology;2023-07-19

5. Immune changes over time and survival in patients with cirrhosis treated with non-selective beta-blockers: A prospective longitudinal study;Biomedicine & Pharmacotherapy;2023-07